Combinostics at ASNR22
Did you miss our team at ASNR22 or want to discuss our products further? Schedule some time to learn more about how our cNeuro® suite, including the cMRI™ and cDSI™ applications, is a complete AI software solution for entire patient care pathways of major neurological disorders. Our comprehensive suite supports early detection, differentiation of diagnosis, treatment planning and monitoring.
Join us for a presentation at ASNR22.
Differential diagnosis of dementias: MRI only diagnostic trend to enable differentiation with imaging alone
Using a combination of science and innovative AI technology, we aim to make a difference in the lives of patients with neurological disorders.
Our cNeuro® suite puts the focus on patients by providing clinicians with objective, systematic insights for confident, evidence-based diagnostic and management decisions.
Patient data from multiple sources are integrated and compared with data from previous patients and healthy controls: demographic information, imaging (cMRI) and other biomarkers, clinical characteristics, and neuropsychology tests.
Applications in the cNeuro® suite:
Our AI-driven software tools support early detection, differential diagnosis, prediction of progression, and monitoring of neurodegenerative disorders.
cMRI provides fully automated brain MRI quantification for increased throughput, greater objectivity, and high-quality reporting for improved patient care.